Home›Companies›Biotech & Pharma›Iantrek

Iantrek, Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 21, 2025·Suggest an edit

About Iantrek

Iantrek is a private company based in White Plains, New York. It has reported $58,163,057 raised in four offerings on Form D since October 2020.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 19, 2025Aug 21, 2025$34,748,596of $41.9M target21$1.6MEquityRule 506(b)Form D ↗
Feb 14, 2025Feb 26, 2025$2,780,366of $5.5M target4$695KDebt, Options, Convertible Promissory NotesRule 506(b)Form D ↗
Aug 4, 2022Aug 17, 2022$15,410,669of $25.0M target25$616KEquityRule 506(b)Form D ↗
Oct 16, 2020Oct 26, 2020$5,223,426fully sold29$180KEquityRule 506(b)Form D ↗
Total, four offerings$58,163,057

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Iantrek's Form D filed Aug 21, 2025.

TI
Tsontcho Ianchulev
Executive officer and director
Also a director at KYS Vision.
TS
Todd Sone
Director
JM
James Mazzo
Director
Also a director at KYS Vision.
AS
Adam Szaronos
Executive officer and director
CT
Casey Tansey
Director
RW
Robert Weinreb
Director
Also a director at KYS Vision.
JW
MH
Michael Haydin
Chief Financial Officer
Also a chief financial officer at KYS Vision.
FT

Earlier filings also listed Jeffrey Weinhuff (director, last listed Aug 2022), Stephen Bloch (director, last listed Oct 2020) and Andrew Corley (director, last listed Oct 2020).

Sources

  1. SECIantrek, Inc. filing history